Considering that decorin is the most abundant proteoglycan capable of regulating myogenesis by acting as a direct antagonist of myostatin and repressing transforming growth factor-β signalling [39], it was not a surprise to observe no changes in decorin at the mRNA or protein level in atrophic patients with COPD (figure 3). Here, DCN is linked to chronic obstructive pulmonary disease.